https://www.selleckchem.com/products/pomhex.html
Hepatitis C virus (HCV) infection is still one of the leading causes of chronic liver disease, with chronically infected making up approximately 1% of the global population. Of those infected, 70% (55-85%) will develop chronic HCV infection. Chronic HCV infection causes substantial morbidity and mortality, with complications including cirrhosis, end-stage liver disease, hepatocellular carcinoma, and eventually death. Therapeutic options for chronic HCV infection have evolved dramatically since 2014, with a translation from pegylated inte
Like
Comment
Share
